Get the Stockscreener App
2.46
5.57%
-0.145
Pre-market:
2.46
Biomerica Inc stock is traded at $2.46, with a volume of 50,979.
It is down -5.57% in the last 24 hours and up +46.43% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$2.605
Open:
$2.6
24h Volume:
50,979
Relative Volume:
0.77
Market Cap:
$11.29M
Revenue:
$4.33M
Net Income/Loss:
$-4.17M
P/E Ratio:
-1.6452
EPS:
-1.4953
Net Cash Flow:
$-3.19M
1W Performance:
+4.24%
1M Performance:
+46.43%
6M Performance:
+13.89%
1Y Performance:
-15.46%
1-Day Range:
$2.44
$2.64
1-Week Range:
$2.30
$2.84
52-Week Range:
$1.45
$3.2133
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.46 | 11.29M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com Australia
Biomerica files prospectus for resale of 1.4 million shares - scanx.trade
Biomerica Stock Price Forecast. Should You Buy BMRA? - StockInvest.us
Biomerica Inc. (BMRA) Holds Near $2.36 as Traders Eye Tight RangeDiamond Pattern - siam.in
Biomerica (BMRA) gets new B. Riley-linked shareholder - stocktitan.net
Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan
Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal
Biomerica Inc. (BMRA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Biomerica (BMRA) Gains 1.35% as Shares Test Key Level Near $2.36Cash Secured Put - dars.gov.et
BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Loo - GuruFocus
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com India
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com
Biomerica net loss hits USD 3.8M in 2026 - Medical Buyer
BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media
Biomerica reports fiscal 2026 revenue and product updates - grafa.com
Biomerica Reports Q4 Results - Orange County Business Journal
Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K - scanx.trade
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView
Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com
Biomerica announces USD 2.23M financing - medicalbuyer.co.in
Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan
BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake - TradingView
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com Canada
Biomerica (BMRA) director joins $1.60 private placement buy - Stock Titan
Biomerica (BMRA) director adds 6,250 shares in private deal - Stock Titan
Biomerica (NASDAQ: BMRA) director adds shares in $1.60 private placement - Stock Titan
Biomerica (NASDAQ: BMRA) director lifts stake to 73,542 shares - Stock Titan
Biomerica (NASDAQ: BMRA) CEO adds 31,250 shares in private placement - Stock Titan
Biomerica Inc. (BMRA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biomerica raises $2.23M in private placement led by B. Riley - Dealroom
Biomerica raises $2.23 million in private placement at $1.60 - Investing.com
Biomerica Announces $2.23 Million Private Placement at $1.60 per Share and Engages B. Riley to Review Strategic Alternatives - Moomoo
Biomerica commences $2.23M private placement of 1.394M shares at $1.60 - scanx.trade
Biomerica, Inc. Hires B. Riley to Consider Strategic Options - marketscreener.com
Biomerica Completes Private Placement of Equity Securities - TipRanks
Biomerica Enters Securities Purchase Agreement for Private Placement With Investors - TradingView
Biomerica (NASDAQ: BMRA) grants B. Riley board designee in $2.23M raise - Stock Titan
Biomerica, Inc. announced that it has received $2.229928 million in funding - marketscreener.com
Biomerica (BMRA) Chart: Ends Up by 4.35% at $1.68; Range View: the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingQuote Data - vinanet.vn
Biomerica (BMRA) Watch: Moves 1.58% Higher to $1.61 in Latest Trading; Immediate View: the Supplied Trading Band Runs From $1.53 to $1.69 in the Available RecordIchimoku Kumo Twist - vinanet.vn
Biomerica, Inc. announced that it expects to receive $2.229928 million in funding - marketscreener.com
BMRA Q2 2026 Earnings: EPS Loss of $0.44 Highlights Cost-Heavy Development PhaseEarnings Season Review - vinanet.vn
Biomerica (BMRA) Slips 2.47% to $1.58 as Shares Test Key Support ZonePassive Flow - dars.gov.et
Biomerica (BMRA) Advances 3.18% to $1.62, Pressing Against Key Resistance at $1.70Volume Rate Change - vinanet.vn
Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomerica (BMRA) Edges Lower to $1.5: Navigating Support and ResistanceStock Picks - vinanet.vn
BMRA Q2 2026 Earnings: Loss of $0.44 Per Share Amid Thin DisclosureBook Value Growth - vinanet.vn
Biomerica Inc (BMRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomerica (BMRA) Q2 2026 Earnings: Net Loss Per Share of -$0.44 Highlights Challenging Quarter - vinanet.vn
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):